The Efficacy of Computerized Alcohol Screening and Intervention (CASI) in At-Risk Emergency Department and Trauma Patients
Public ClinicalTrials.gov record NCT01680614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research is to examine the effectiveness of computerized alcohol screening and brief intervention in the UC Irvine Medical Center Emergency Department (ED) and Trauma Patients. Brief interventions have a high potential impact in ED and Trauma populations. Computerized alcohol screening and brief intervention (CASI) is a fast and easy to use tool for patients and healthcare providers. CASI mitigates barriers to proper screening and intervention, including time, availability of trained personnel, patient comfort, and language barriers. CASI provides the Alcohol Use Disorders Identification Test (AUDIT) followed by a brief intervention and customized alcohol intake recomendations for the patient. The intervention of this study will be the addition of a brief CASI questionnaire to the standard of care for a random subset of subjects. All subjects who screen positive for hazardous alcohol use will be followed up and reassessed for alcohol use. The researchers hypothesize that the addition of CASI will lead to a decrease in alcohol intake within three months. The basis of this research is evidence of the effectiveness in the CASI system, the growing public health issue of alcohol abuse, the need to be able to provide effective screening and brief intervention in the high volume ED settings, and findings that the primary method to reduce traumatic death is prevention.
Study identification
- NCT ID
- NCT01680614
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 2,114 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 1, 2013 (Actual)
- Primary completion
- Jun 1, 2015 (Actual)
- Completion
- Jun 29, 2015 (Type not available)
- Last update posted
- Oct 26, 2017
2013 – 2015
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC Irvine Medical Center | Orange | California | 92868 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01680614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2017 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01680614 live on ClinicalTrials.gov.